Actemra 160mg, a medication known scientifically as tocilizumab, functions as a potent pharmaceutical agent primarily used for the control of rheumatoid arthritis. This remarkable compound acts by blocking the activity of interleukin-6 (IL-6), a signaling protein vital in the inflammatory process. Furthermore, Actemra exhibits effectiveness in the